BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38200447)

  • 1. T1 mapping as a quantitative imaging biomarker for diagnosing cervical cancer: a comparison with diffusion kurtosis imaging.
    Zhang Z; Liu J; Zhang Y; Qu F; Grimm R; Cheng J; Wang W; Zhu J; Li S
    BMC Med Imaging; 2024 Jan; 24(1):16. PubMed ID: 38200447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma.
    Hou M; Song K; Ren J; Wang K; Guo J; Niu Y; Li Z; Han D
    BMC Cancer; 2022 Jan; 22(1):87. PubMed ID: 35057777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal magnetic resonance imaging in the diagnosis of cervical cancer and its correlation with the differentiation process of cervical cancer.
    Meng H; Guo X; Zhang D
    BMC Med Imaging; 2023 Sep; 23(1):144. PubMed ID: 37773061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-tumor texture model based on diffusion kurtosis imaging for assessing cervical cancer: a preliminary study.
    Zhang Q; Yu X; Ouyang H; Zhang J; Chen S; Xie L; Zhao X
    Eur Radiol; 2021 Aug; 31(8):5576-5585. PubMed ID: 33464399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the amide proton transfer-weighted imaging and diffusion kurtosis imaging in the study of cervical cancer.
    Meng N; Wang X; Sun J; Han D; Ma X; Wang K; Wang M
    Eur Radiol; 2020 Oct; 30(10):5758-5767. PubMed ID: 32424593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T1 mapping and multimodel diffusion-weighted imaging in the assessment of cervical cancer: a preliminary study.
    Li S; Liu J; Zhang W; Lu H; Wang W; Lin L; Zhang Y; Cheng J
    Br J Radiol; 2023 Aug; 96(1148):20220952. PubMed ID: 37183908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T
    Li S; Liu J; Guo R; Nickel MD; Zhang Y; Cheng J; Zhu J
    NMR Biomed; 2023 Aug; 36(8):e4918. PubMed ID: 36914267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion Kurtosis Imaging in the Assessment of Cervical Carcinoma.
    Wang M; Perucho JAU; Chan Q; Sun J; Ip P; Tse KY; Lee EYP
    Acad Radiol; 2020 May; 27(5):e94-e101. PubMed ID: 31324577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion kurtosis imaging (DKI) of hepatocellular carcinoma: correlation with microvascular invasion and histologic grade.
    Cao L; Chen J; Duan T; Wang M; Jiang H; Wei Y; Xia C; Zhou X; Yan X; Song B
    Quant Imaging Med Surg; 2019 Apr; 9(4):590-602. PubMed ID: 31143650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship of diffusion kurtosis imaging parameters with the pathologic type and prognosis of rectal tumors].
    Li J; Gao XM; Cheng JL
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1208-1213. PubMed ID: 36380670
    [No Abstract]   [Full Text] [Related]  

  • 11. Grading and proliferation assessment of diffuse astrocytic tumors with monoexponential, biexponential, and stretched-exponential diffusion-weighted imaging and diffusion kurtosis imaging.
    Zhang J; Chen X; Chen D; Wang Z; Li S; Zhu W
    Eur J Radiol; 2018 Dec; 109():188-195. PubMed ID: 30527302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of lymphovascular space invasion in cervical carcinoma using diffusion kurtosis imaging.
    Malek M; Rahmani M; Pourashraf M; Amanpour-Gharaei B; Zamani N; Farsi M; Ahmadinejad N; Raminfard S
    Cancer Treat Res Commun; 2022; 31():100559. PubMed ID: 35460974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis for detection and grading of hepatocellular carcinoma: Comparison of diffusion kurtosis imaging, intravoxel incoherent motion and conventional diffusion-weighted imaging.
    Li HW; Yan GW; Yang J; Zhuo LH; Bhetuwal A; Long YJ; Feng X; Yao HC; Zou XX; Feng RH; Yang HF; Du Y
    Oncol Lett; 2022 Nov; 24(5):403. PubMed ID: 36276491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging.
    Chen W; Li L; Yan Z; Hu S; Feng J; Liu G; Liu B; Liu X
    Eur Radiol; 2021 May; 31(5):3286-3296. PubMed ID: 33125558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of magnetic resonance diffusion kurtosis imaging for distinguishing histopathologic subtypes and grades of rectal carcinoma.
    Wen Z; Chen Y; Yang X; Lu B; Liu Y; Shen B; Yu S
    Cancer Imaging; 2019 Feb; 19(1):8. PubMed ID: 30744694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diffusion-weighted imaging mono-exponential mode with diffusion kurtosis imaging for predicting pathological grades of clear cell renal cell carcinoma.
    Cao J; Luo X; Zhou Z; Duan Y; Xiao L; Sun X; Shang Q; Gong X; Hou Z; Kong D; He B
    Eur J Radiol; 2020 Sep; 130():109195. PubMed ID: 32763475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated pretreatment diffusion kurtosis imaging and serum squamous cell carcinoma antigen levels: a biomarker strategy for early assessment of radiotherapy outcomes in cervical cancer.
    Zheng X; Shen F; Chen W; Ren W; Tang S
    Abdom Radiol (NY); 2024 May; 49(5):1502-1511. PubMed ID: 38536425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted and diffusion kurtosis imaging analysis of microstructural differences in clear cell renal cell carcinoma: a comparative study.
    Zou J; Ye J; Zhu W; Wu J; Chen W; Chen R; Zhu Q
    Br J Radiol; 2023 Oct; 96(1150):20230146. PubMed ID: 37393526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic Resonance Diffusion Kurtosis Imaging versus Diffusion-Weighted Imaging in Evaluating the Pathological Grade of Hepatocellular Carcinoma.
    Wang GZ; Guo LF; Gao GH; Li Y; Wang XZ; Yuan ZG
    Cancer Manag Res; 2020; 12():5147-5158. PubMed ID: 32636677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.